Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
PUT
DaVita
DVA
$11.3B
| $41.6M | 0.02% |
+413,900
| New | +$38.4M |
|
852
Erie Indemnity
ERIE
$14.1B
| $41.6M | 0.02% |
197,889
+194,927
| +6,581% | +$43.5M |
|
853
PUT
Altria Group
MO
$114B
| $41.6M | 0.02% |
917,400
-533,100
| -37% | -$24.1M |
|
854
Amylyx Pharmaceuticals
AMLX
$4.25B
| $41.4M | 0.02% |
1,921,631
+847,021
| +79% | +$22.9M |
|
|
AY
855
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $41.3M | 0.02% |
1,762,295
+603,293
| +52% | +$15.5M |
|
856
Kirby Corp
KEX
$7.32B
| $41.3M | 0.02% |
536,078
+211,522
| +65% | +$15.2M |
|
857
PUT
Stryker
SYK
$126B
| $41.2M | 0.02% |
134,900
+40,200
| +42% | +$11.6M |
|
858
CALL
Royal Bank of Canada
RY
$283B
| $41.1M | 0.02% |
325,000
-200,000
| -38% | -$19.1M |
|
859
Atkore
ATKR
$3.16B
| $41.1M | 0.02% |
263,680
+245,851
| +1,379% | +$32.2M |
|
860
Cameco
CCJ
$44.5B
| $41.1M | 0.02% |
1,311,347
+175,437
| +15% | +$4.93M |
|
861
Celestica
CLS
$37.1B
| $41.1M | 0.02% |
2,831,265
+674,395
| +31% | +$8.34M |
|
862
CALL
Costco
COST
$431B
| $41M | 0.02% |
76,200
+9,900
| +15% | +$5.01M |
|
863
Outset Medical
OM
$78.2M
| $41M | 0.02% |
125,007
+102,845
| +464% | +$31.4M |
|
864
Sonos
SONO
$1.82B
| $40.9M | 0.02% |
2,503,306
+2,399,154
| +2,304% | +$42.5M |
|
865
PUT
Accenture
ACN
$114B
| $40.8M | 0.02% |
132,100
-146,100
| -53% | -$42.5M |
|
866
Unilever
UL
$141B
| $40.7M | 0.02% |
693,238
-255,924
| -27% | -$15.2M |
|
867
Viatris
VTRS
$19B
| $40.7M | 0.02% |
4,073,716
+3,498,412
| +608% | +$33.4M |
|
868
Ingredion
INGR
$6.7B
| $40.6M | 0.02% |
383,423
+26,043
| +7% | +$2.77M |
|
869
PUT
Enbridge
ENB
$109B
| $40.6M | 0.02% |
825,000
-102,400
| -11% | -$3.9M |
|
870
Public Storage
PSA
$60.7B
| $40.6M | 0.02% |
139,080
+120,394
| +644% | +$35.1M |
|
871
Expeditors International
EXPD
$24.4B
| $40.6M | 0.02% |
335,052
+180,866
| +117% | +$20.6M |
|
872
CALL
Freeport-McMoran
FCX
$112B
| $40.5M | 0.02% |
1,011,800
+455,600
| +82% | +$17.4M |
|
|
SQSP
873
DELISTED
Squarespace, Inc.
SQSP
| $40.4M | 0.02% |
1,279,914
+302,680
| +31% | +$9.14M |
|
874
Wyndham Hotels & Resorts
WH
$5.52B
| $40.4M | 0.02% |
588,613
+443,948
| +307% | +$30.3M |
|
875
CALL
ServiceNow
NOW
$132B
| $40.3M | 0.02% |
359,000
+331,000
| +1,182% | +$33.1M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.